PEDI GU REVIEW oncology i

PEDIATRIC ONCOLOGY Pediatric GU Review UCSD Pediatric Urology George Chiang MD Sara Marietti MD Outlined from The Kelalis-King-Belman Textbook of Clinical Pediatric Urology 2007 (not for reproduction, distribution, or sale without consent)

Wilm’s Tumor ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Wilm’s Presentation ,[object Object],[object Object],[object Object],[object Object]

Wilm’s Imaging ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Wilm’s Genetics ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Wilm’s: Associated Anomalies ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Wilm’s Staging ,[object Object],[object Object],[object Object],[object Object],[object Object]

Wilm’s Pathology ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Wilm’s Treatment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Wilm’s Surgery ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

EE 4A = dactinomycin, vincristine DD 4A = dactinomycin, vincristine, doxorubicin Reg I = dactinomycin, vincristine, doxorubicin, cyclophosphamide, etoposide Reg RTK = carboplatin, etoposide, cyclophosphamide Stage XRT Chemo I/II FH - EE-4A III/IV FH, I UH + DD-4A II-IV, focal anaplasia + DD-4A II-IV, diffuse anaplasia + Regimen I I-IV CCSK/rhabdoid + Reg. RTK

Other Renal Neoplasms ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Renal Cell Carcinoma ,[object Object],[object Object],[object Object],[object Object],[object Object]

Neuroblastoma ,[object Object],[object Object],[object Object],[object Object],[object Object]

NB - Presentation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

NB - Diagnosis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Poor Prognosis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Evans Staging ,[object Object],[object Object],[object Object],[object Object],[object Object]

International Neuroblastoma Staging System ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

NB - Therapy ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Rhabdomyosarcoma ,[object Object],[object Object],[object Object],[object Object],[object Object]

RMS: Pathology ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

RMS: Presentation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

RMS: Evaluation and Therapy ,[object Object],[object Object],[object Object],[object Object]

Post Op Grouping for RMS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Post Op Grouping for RMS ,[object Object],[object Object],[object Object]

RMS: Risk Stratification ,[object Object],[object Object],[object Object]

RMS: Chemotherapy ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Testicular Tumors ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Yolk Sac Tumors: Diagnosis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Yolk Sac Tumors: AFP ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

YST: Staging ,[object Object],[object Object],[object Object],[object Object]

YST: Treatment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Teratoma ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Leydig Cell Tumor ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Gonadoblastoma ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Paratesticular RMS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Juvenile Granulosa Cell Tumor ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

PEDI GU REVIEW oncology i

Recommandé

Recommandé

Contenu connexe

Tendances

Tendances (20)

En vedette

En vedette (20)

Similaire à PEDI GU REVIEW oncology i

Similaire à PEDI GU REVIEW oncology i (20)

Dernier

Dernier (20)

PEDI GU REVIEW oncology i